Other Information
−Removed: Without limiting the generality of the foregoing, during the three months ended June 30, 2024 , no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement,” or any “non-Rule 10b-5 trading arrangement,” as such terms are defined in Item 408(a) of Regulation S-K.
−Removed: Asset Purchase Agreement, dated as of April 18, 2024, by and among certain subsidiaries of Community Health Systems, Inc.
−Removed: and Hamilton Health Care System, Inc.
−Removed: and certain of its affiliates (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed April 18, 2024 (No.
−Removed: Collateral Agency Transfer Agreement, dated as of April 30, 2024, among Credit Suisse AG and Credit Suisse AG, Cayman Islands Branch, together as Predecessor Collateral Agent, Regions Bank, as Trustee and Authorized Representative, U.S.
−Removed: Bank Trust Company, National Association, as Successor Collateral Agent, CHS/Community Health Systems, Inc., Community Health Systems, Inc.
−Removed: and the guarantors party thereto
−Removed: First Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 10.875% Senior Secured Notes due 2032, dated as of June 5, 2024, among CHS/Community Health Systems, Inc., Community Health Systems, Inc., the guarantors party thereto, Regions Bank, as trustee, and U.S.
−Removed: Bank Trust Company, National Association, as collateral agent (incorporated by reference to Exhibit 4.2 to Community Health Systems, Inc.’s Current Report on Form 8-K filed on June 5, 2024 (No.
−Removed: Second Amendment and Restatement Agreement to the Amended and Restated ABL Credit Agreement, dated as of June 5, 2024, among CHS/Community Health Systems, Inc., as Borrower, Community Health Systems, Inc., as the Parent, the subsidiaries of the Borrower party thereto, the lenders party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to Community Health Systems, Inc.’s Current Report on Form 8-K filed on June 5, 2024 (No.
+Added: Without limiting the generality of the foregoing, during the three months ended September 30, 2024 , no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement,” or any “non-Rule 10b-5 trading arrangement,” as such terms are defined in Item 408(a) of Regulation S-K.
+Added: Asset Purchase Agreement, dated as of April 18, 2024, by and among CHS/Community Health Systems, Inc., certain subsidiaries of CHS/Community Health Systems, Inc.
+Added: and Hamilton Health Care Systems, Inc.
+Added: and certain of its affiliates, as amended (incorporated by reference to Exhibit 2.1 to Community Health Systems, Inc.'s Current Report on Form 8-K filed on August 1, 2024 (No.
+Added: Asset Purchase Agreement, dated as of July 30, 2024, by and among, CHS/Community Health Systems, Inc., certain subsidiaries of CHS/Community Health Systems, Inc.
+Added: and WoodBridge Healthcare, Inc.
+Added: and certain of its affiliates, as amended.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
4 unchanged sentences
Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: The following financial information from our quarterly report on Form 10-Q for the quarter and six months ended June 30, 2024 and 2023, filed with the SEC on July 25, 2024, formatted in Inline Extensible Business Reporting Language:
−Removed: (i) the condensed consolidated statements of loss for the three and six months ended June 30, 2024 and 2023, (ii) the condensed consolidated statements of comprehensive loss for the three and six months ended June 30, 2024 and 2023, (iii) the condensed consolidated balance sheets at June 30, 2024 and December 31, 2023, (iv) the condensed consolidated statements of cash flows for the six months ended June 30, 2024 and 2023, and (v) the notes to the condensed consolidated financial statements.
+Added: The following financial information from our quarterly report on Form 10-Q for the quarter and nine months ended September 30, 2024 and 2023, filed with the SEC on October 24, 2024, formatted in Inline Extensible Business Reporting Language:
+Added: (i) the condensed consolidated statements of loss for the three and nine months ended September 30, 2024 and 2023, (ii) the condensed consolidated statements of comprehensive loss for the three and nine months ended September 30, 2024 and 2023, (iii) the condensed consolidated balance sheets at September 30, 2024 and December 31, 2023, (iv) the condensed consolidated statements of cash flows for the nine months ended September 30, 2024 and 2023, and (v) the notes to the condensed consolidated financial statements.
The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
9 unchanged sentences
Chief Accounting Officer
−Removed: July 25, 2024
+Added: October 24, 2024
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.